| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/08/2008 | WO2008053340A1 A combination product comprising at least one lipid substituted in the alpha position and at least one hypoglycemic agent |
| 05/08/2008 | WO2008053331A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| 05/08/2008 | WO2008053256A1 Reduction of overweight or obesity |
| 05/08/2008 | WO2008053025A1 Therapeutic use of gba2 |
| 05/08/2008 | WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors |
| 05/08/2008 | WO2008052769A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 05/08/2008 | WO2008052658A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties |
| 05/08/2008 | WO2008052638A1 DIAZEPANE-ACETAMIDE DERIVATIVES AS SELECTIVE 11β-HSD1 INHIBITORS |
| 05/08/2008 | WO2008052444A1 Compounds with a six-membered heterocyclic ring, their preparing method and pharmaceutical use |
| 05/08/2008 | WO2008036308A3 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| 05/08/2008 | WO2008015099A3 Pegylated, extended insulins |
| 05/08/2008 | WO2008002591A3 Methods for treating atherosclerosis |
| 05/08/2008 | WO2007149797A3 Use of organic compounds |
| 05/08/2008 | WO2007085970A3 Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders |
| 05/08/2008 | WO2007060038A3 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108705 Treatment of diabetes with copper bunding compounds |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108673 Prevention and Treatment of Obesity |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108653 Tripeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108640 Method of restoring the incretin effect |
| 05/08/2008 | US20080108630 Substituted triazoles as modulators of ppar and methods of their preparation |
| 05/08/2008 | US20080108629 Heterocyclic Derivatives for the Treatment of Diseases Mediated by Stearoyl-Coa Desaturase Enzymes |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |
| 05/08/2008 | US20080108620 N-(4-{(1S)-1-[3-(3,5-DICHLOROPHENYL)-5-QUINOLIN-3-YL-1H-PYRAZOL-1-YL]ETHYL}BENZOYL)- beta -ALANINE; glucagon receptor antagonists; antidiabetic agent; insulin resistance and its complications, including coronary heart disease, stroke, hypertension, nephropathy, neuropathy, retinopathy; atherosclerosis |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108604 sugar transport enhancement agent; antidiabetic and hypoglycemic agent; obesity, diabetic nephropathy, retinopathy, macrovascular disease, glucose tolerance anomaly; cyclization of 4-(2-aminocyclohexylamino)-3-pyrroline-2-one by aldehyde followed by acylation |
| 05/08/2008 | US20080108602 Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication |
| 05/08/2008 | US20080108598 Pharmaceutical use of substituted amides |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108590 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/08/2008 | US20080108580 1-Bromo-4-deoxy-4-fluoro-2,3,6-tri-O-acetyl-alpha-D-galactose derivatives; antidiabetic agent |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080107760 Beverage and medicament containing bamboo extract as a main ingredient |
| 05/08/2008 | US20080107732 Gastric Retention System |
| 05/08/2008 | US20080107677 Culture filtrate concentrate from Basidiomycetes; Parkinson's disease; diabetes |
| 05/08/2008 | US20080107604 Method for the Prediction of the Risk Potential for Cancerous Diseases and Inflammatory Intestinal Diseases and Corresponding Tests |
| 05/08/2008 | US20080105961 Ligands of the Molecule Fit (Agt-121) and their Pharmaceutical Use |
| 05/08/2008 | DE102006052560A1 Anti-diabetogene Calcium-Peptid-Zusammensetzung Anti-diabetogenic calcium peptide composition |
| 05/08/2008 | CA2668504A1 Diazepane-acetamide derivatives as selective 11.beta.-hsd1 inhibitors |
| 05/08/2008 | CA2668491A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| 05/08/2008 | CA2668382A1 Reduction of overweight or obesity |
| 05/08/2008 | CA2668312A1 Nutritional products comprising saccharide oligomers |
| 05/08/2008 | CA2668094A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties |
| 05/08/2008 | CA2667856A1 Use of nutritional compositions for preventing disorders |
| 05/08/2008 | CA2667759A1 Use of nutritional compositions for preventing disorders |
| 05/08/2008 | CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors |
| 05/08/2008 | CA2667211A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918373A1 Anti-obesity agent and anti-obesity food |
| 05/07/2008 | EP1918285A1 Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors |
| 05/07/2008 | EP1918281A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918000A2 Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
| 05/07/2008 | EP1917962A1 Pharmaceutical composition for modified release insulin sensitiser |
| 05/07/2008 | EP1917961A1 Capsinoid containing composition |
| 05/07/2008 | EP1917247A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 05/07/2008 | EP1917025A2 Compositions comprising insulin and c-peptide for treating diabetes |
| 05/07/2008 | EP1916913A2 Protein composition for treating a physiologically caused, clinically normal increased need for protein |
| 05/07/2008 | EP1761519B1 Indole derivatives as histamine receptor antagonists |
| 05/07/2008 | EP1528931B1 Dipeptidyl peptidase iv inhibitors for decreasing the rate of chronic weight gain |
| 05/07/2008 | EP1480951B1 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 05/07/2008 | EP1383774B1 Dihydroimidazo¬4,5-e indole and 7h-pyrrolo¬3,2-f quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1372688B1 Somatostatin antagonists |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | EP1339409B1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 05/07/2008 | EP1137666B1 Glp-1 analogues |
| 05/07/2008 | CN101175759A Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/07/2008 | CN101175731A Pyrimidine carboxylic acid derivatives and use thereof |
| 05/07/2008 | CN101175720A New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 05/07/2008 | CN101175494A Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism |
| 05/07/2008 | CN101175416A A method and composition for nutritionally improving glucose control and insulin action |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101173281A Rhabdophis tigrinus uncoupling protein gene -SA and uses thereof |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/07/2008 | CN101172978A Six-member heterocyclic compounds, prepare method and medical uses of the same |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN101172140A Nutritive composition for accelerating hemopoietic stem cell proliferation and hemoglobin synthesis |
| 05/07/2008 | CN101172130A Jinqi sugar lowering condensed pill and preparation method thereof |
| 05/07/2008 | CN101172126A Traditional Chinese medicine composition for health care beauty treatment |
| 05/07/2008 | CN101172109A Medicine use of potentilla plants total-triterpene extract |
| 05/07/2008 | CN101172101A Glipizide controlled release tablets and preparation method thereof |
| 05/07/2008 | CN101171949A Health-care cold tea |
| 05/07/2008 | CN101171927A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/07/2008 | CN100386427C Bifidobacterium and products containing the same |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386316C Mixtures and compounds from Antrodia camphorate myceliums and use thereof |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/07/2008 | CN100386114C Antidiabetic formulation and method |
| 05/07/2008 | CN100386101C Natural medicine for reducing blood fat and its production method |
| 05/06/2008 | US7368605 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 05/06/2008 | US7368583 Process for recovery of plant sterols from by-product of vegetable oil refining |